It isIt illegal to post this copyrighted PDF on any website. Bethesda, MD 20814 ([email protected]) 5415 Ste 201-B, Ln, WCedar Network, Collaborative * Baltimore, Maryland Hopkins Hospital/Bloomberg Children’s Center, Prim Care Companion CNSDisord 2017;19(4):17r02122 For [email protected]. reprints orpermissions, contact ♦ c b a © Copyright 2017Physicians Postgraduate Press, Inc. https://doi.org/10.4088/PCC.17r02122 2017;19(4):17r02122 Prim Care Companion CNSDisord guide clinicaltherapeutics. children lessthan10years ofageto better need for comparative effectiveness data in current casealsohighlights thegreat unmet prospective monitoring appearsessential. The young childrenin very asillustrated here, course ofmanyhighly fluctuating symptoms response ofthechildto treatment. Given the visualize course and ofsymptom fluctuations systematic longitudinal ratings to helpbetter their introduction. We encourage theuseof treatment optionsandapossiblesequence for or risperidone. We arange describe ofother remained inadequately responsive to lithium Board–approved protocol. This 9-year-old girl Review Institutional under aJohnsHopkins basisintheChildNetwork plotted onaweekly behavior, andmaniaare rated by aparent and disorder,deficit/hyperactivity oppositional symptoms ofdepression, anxiety, attention- rarely utilized. We present apatient whose for ofsymptoms longitudinalare tracking systematic database, clinicaltrial andsystems are notadequately orbasedona described multisymptomatic childwithbipolardisorder Treatment sequences for the M.Post, MD Robert How to Track and Treatment Sequence A Multisymptomatic With Child Bipolar Disorder: Study Case Maryland Washington, DC Medicine, of School University Washington George ABSTRACT Division of Child and Adolescent Psychiatry, Johns Johns Psychiatry, Adolescent and Child of Division Department of Psychiatry and Behavioral Sciences, Sciences, Behavioral and Psychiatry of Department Bipolar Collaborative Bethesda, Network, Corresponding author: Robert M. Post, MD, Bipolar MD, Bipolar Post, M. Robert a,b, * ; Michael Rowe, PhD; Michael . b C ; DanaKaplan, MPH DSM-5, dysphoric dysregulation mood disorder. of dysregulation severe mood and its relative close recently to added the debate and diagnoses disagreementthe about and frequency the of specificity opinion extrapolated from controlled studies inadults and is largely on expert based studies allow children under age 10to enter, and most information is adequatelybeen studied or elucidated. Few controlled or industry-supported bipolarnews.org ratings of 5symptom domains available for Network Child inthe free (www. and illustrate unique the advantages of more regular (weekly) prospective to-treat child with acomplex, multifaceted presentationbipolar disorder of about adialogue begin treatment alternatives and sequences for difficult- the of We dysfunction scale. present current the description case inorder to degree of1-year) symptomatology retrospectivethe ratings of on a severity measuressectional of psychopathology (usually 6-month or periodic to symptomatic as much as two-thirds of of time the follow-up. outpatients course on tend adifficult prospective to run follow-up, remaining multifaceted, and accompanied by multiple comorbidities. inpatients Both and States compared to European children. young in illness very children,presentationbipolar spectrum of I disorder (BP-I). Yet, is most the bipolar common specified not otherwise bipolar disorder than inadulthood inchildhood adversethis course is related to amore presentation seriousand difficult of once bipolar has illness emerged, common precursors to BP-I and BP-II and diagnoses frequent comorbidities hyperactivity disorder (ADHD), and disruptive behavior disorders are was superiordrug to lithium-valproate the combination). phase and inasecond combination phase (ie, risperidone plus either other risperidone over lithium both and valproate in first the both monotherapy patientsbipolar whereinmixed foundspectrum group they superiority of of inadequate treatment by etal Geller children are rarely systematically studied. One notable exception is study the among clinicians, as well as amuch-neededtreatment round new studies. of literature,in the we help hope discussion this will engender dialogue anew helpful of to child. child type this Given of systematic dearth this the studies of speculate about what treatments, of all are which off-label, might more be that treatments these remain speculative and perhaps controversial. We then multisymptomatic child with bipolar disorder with awareness the and caveat approaches disorders to these have not defined. also been syndromes are associated with considerable dysfunction, therapeutic the The therapeutic approaches to bipolar childhood-onset have illness not Most longitudinal follow-up is accomplished with either repeated cross- Complicating picture the are findings the that anxiety, attention-deficit/ Given deficitsliterature, inthe these we treatment discuss options for the episodes ofepisodes pure mania or depression, but more often fluctuating, is highly bipolarhildhood-onset disorder is rarely characterized by distinct 10,11 aimed almost entirely towardbipolar children with adiagnosis of 12 assessing randomized lithium, valproate, or risperidone in a ; click on Network). Child c 6 ; and Robert L.Findling, MD; andRobert is unknown. © 2017Copyright Physicians Postgraduate Press, Inc. 2,13–15 particularly inchildren particularly United inthe 16,17 In addition, there is considerable 7 as opposed to delayed c 18 Although latter these 1–6 How much of 3 and these
8,9 e1 or or
You are prohibited from making this PDF publicly available. Clinical Points parent could print out is similar to that illustrated inFigure year. completed degree of with ahigh consistency for almost 1 5 symptom domains, which take just a few minutes, were 15–20 minutes to complete. the Then, weekly the ratings of symptoma detailed checklist, eachof about take which child maythe have already received community), inthe and demographics questionnaire includes (which what diagnoses informed consent for into entry naturalistic this study, a response to treatment. or physician to more evaluate easily symptom course and longitudinal ratings and bring to atreating these clinician Network is ability the of parents to print out weekly the Child the and Akey element behavioralmood difficulties. of were currentlythey asymptomatic or already experiencing indicated, and and sideeffects tolerability are rated. Post etal e2 For [email protected]. reprints orpermissions, contact ♦ mania. depression, anxiety, ADHD, oppositional behavior, and receive e-mails each Sunday of severity for the ratings of form and amore symptom detailed checklist and then consent,background/demographics parents out fill abrief Hopkins Institutional Board. After an informed Review under auspices the of a protocol approved by Johns the years to rate child their on aweekly basis on website asecure andillness response of or response inadequacy to treatment. weekly ratingsthe in describing course the of utilitythe of lithium, risperidone, guanfacine, or melatonin. We illustrate behavior, and mania) had who not adequately responded to (including anxiety, depression, ADHD, oppositional a complex presentation of multiple symptom domains METHODS It isIt illegal to post this copyrighted PDF on any website. ■ ■ ■ The longitudinal chart of the weekly ratingsThe longitudinalthe that the chart of In current the patient’s the case, father completed the Parents could enter children into Network Child the if The Child NetworkThe Child enlists parents of children aged 2–12 Here, we present study a case of a9-year-old with girl ■ ■ ■
symptom course anddegree ofimprovement. physicians inagraphic format for easeofvisualization of and presenting theseandthetreatments employed to disorder,hyperactivity oppositionalbehavior, andmania symptoms ofanxiety, depression, attention-deficit/ bipolarnews.org) andrating basistheirchild’s onaweekly to physicians by (at joiningtheChildNetwork www. Parents canprovide ofinputandfeedback thistype optimal therapeutic regimen. an building canbeamosthelpfulwayinterventions of child’s response to pharmacologic andpsychosocial individual the to adetailedlongitudinal record of a systematic literature to guidetherapeutics, access Given thiscomplexityofpresentation of andpaucity associated withdysfunction. haveoften multiplecomorbidities andsymptoms Children withbipolardisorders andrelated conditions 19 Pharmacologic or treatments psychosocial are present, 1 behavior, and mania graphed has been as rated as 0 symptomsthe of anxiety, depression, ADHD, oppositional of presentation weekly ratingsthe of for of journal. the Each for modified clarity figure has1, but been the format the of of BP-I considerable (DSM-5 illness experienced ). She also patient would now most likely criteria meet for adiagnosis andOctober November 2015), it would appear that this CourseIllness and symptom detailed (2)the checklist. entirelythen consistent with community (1)the diagnoses oppositional behavior, and mania illustrated inFigure 1were prospective weekly ratings of anxiety, depression, ADHD, 21 of 24, and disruptive behavioral disorder 19 of 40. (3) The was scored 15of amaximum of 52,anxiety 24of 32,ADHD hypomania lasting at least 4days, was positive. Depression 47 of amaximum score of 68,and adescription of BP-II, ie, 2 previousthe weeks. For example, mania items were scored behaviors and symptoms that in child had the experienced corresponded well parental with detailed (2)the checklist of community obtained from demographics the questionnaire compulsive disorder. (1)retrospective These inthe diagnoses school phobia, generalized anxiety disorder, and obsessive- having BP-II and 3anxiety disorder comorbidities, including community, patient the previously had been as diagnosed depression ratings, and an exacerbation in ADHD symptoms. littlemild), change in moderate but fluctuating highly improvement in mania (from mostly moderate to mostly 1.7mg/d) inJunedose 2016appeared to result insome moderate range severity (not illustrated). and weekly ratings of overall remained illness largely inthe generally also less severe from 2015 to July December 2016, moderate depression re-emerged inApril was 2016.Anxiety fromduring November period the 2015to March 2016,and (up to a day), 9,800 ug twice oppositional behavior worsened 1 mg/d). However, despite continued treatment with lithium with previously the guanfacine started 1mg/d and melatonin orotatelithium introductionthe of (4,800ugincombination depression, and ADHD initially appeared to improve with obtained. consent for weekly symptoms publicationthe was of tohave maintain modified been anonymity, and informed therapyfamily-focused and and home special schooling. are not illustrated here, althoughincluded they intermittent different psychotherapies that were employed were rated, but and are doses their plotted above symptoms, the the while usual family, or educational social, roles. treatments Drug degree of dysfunction that was associated with child’s the RESULTS Given 6 the weeks of moderate to severe mania (in The patient’s in 3 ways. diagnosis was assessed In the The switch from lithium to risperidone (maximum As illustrated inFigure 1,many weeks of severe mania, demographic and girl case the attributesthe this of All of © 2017Copyright Physicians Postgraduate Press, Inc. Prim Care Companion CNSDisord 2017;19(4):17r02122 = mild, 2moderate, and 3 = severe based on thesevere based = not
You are prohibited from making this PDF publicly available. Figure 1. Longitudinal Chart of the Child’sthe Figure of 1.Longitudinal Chart Weekly Ratings That theParent Could Print Prim Care Companion CNSDisord 2017;19(4):17r02122 For [email protected]. reprints orpermissions, contact ♦ It isIt illegal to post this copyrighted PDF on any website. 9 1 1 uan acine 1mg Se erity Score Melatonin 1mg 2 1
Se erity Score 0 1 2 9 10 1 1 2 1 0 1 2 1 9 1 1 1 10 1 10 11 1 1 1 1 1 11 1 11 12 1 1 1 1 1 I D 12 1 ithium orotate 12 P